| Literature DB >> 12517305 |
George Bertsias1, Ioannis Mammas, Manolis Linardakis, Anthony Kafatos.
Abstract
BACKGROUND: Recent data indicate increasing rates of adult obesity and mortality from cardiovascular disease (CVD) in Greece. No data, however, are available on prevalence of overweight and obesity in relation to CVD risk factors among young adults in Greece.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12517305 PMCID: PMC140012 DOI: 10.1186/1471-2458-3-3
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Blood glucose and lipidaemic profiles of University of Crete medical students
| BG (mmol/l) | 4.73 ± 0.59 | 4.59 ± 0.56 | <0.001 |
| TC (mmol/l) | 4.65 ± 0.91 | 4.63 ± 0.87 | NS5 |
| TG (mmol/l) | 0.83 ± 0.43 | 0.66 ± 0.28 | <0.001 |
| HDL-C (mmol/l) | 1.19 ± 0.30 | 1.44 ± 0.35 | <0.001 |
| LDL-C (mmol/l) | 3.01 ± 0.86 | 2.86 ± 0.82 | 0.010 |
| TC:HDL-C | 4.12 ± 1.30 | 3.40 ± 1.02 | <0.001 |
1 N = 527 except for BG analysis where N = 412. 2 N = 462 except for BG analysis where N = 346. 3 Standard deviation. 4 ANCOVA (adjusting for the year of examination) for differences between the two genders. 5 Not significant.
Distribution of obesity indices, blood pressure, glucose, and lipoproteins among University of Crete medical students
| < 20.0 | 30 | 5.7 | 83 | 18.0 | <0.001 |
| 20.1–24.9 | 289 | 54.8 | 271 | 58.7 | |
| 25.0–29.9 | 181 | 34.4 | 92 | 19.9 | |
| ≥ 30.0 | 27 | 5.1 | 16 | 3.4 | |
| < 90 (♂) – < 80 (♀) | 355 | 67.4 | 361 | 78.1 | <0.001 |
| ≥ 90 (♂) – ≥ 80 (♀) | 172 | 32.6 | 101 | 21.9 | |
| < 0.9 (♂) – < 0.8 (♀) | 369 | 70.0 | 321 | 69.5 | NS2 |
| ≥ 0.9 (♂) – ≥ 0.8 (♀) | 158 | 30.0 | 141 | 30.5 | |
| < 50.0 | 329 | 62.4 | 403 | 87.2 | <0.001 |
| ≥ 50.0 | 198 | 37.6 | 59 | 12.8 | |
| < 130/85 | 272 | 51.6 | 295 | 63.9 | <0.001 |
| ≥ 130/85 – < 140/90 | 185 | 35.1 | 136 | 29.4 | |
| ≥ 140/90 | 70 | 13.3 | 31 | 6.7 | |
| < 6.1 | 404 | 98.1 | 344 | 99.4 | NS |
| ≥ 6.1 | 8 | 1.9 | 2 | 0.6 | |
| < 5.2 | 390 | 74.0 | 352 | 76.2 | NS |
| 5.2–6.1 | 109 | 20.6 | 90 | 19.5 | |
| ≥ 6.2 | 28 | 5.4 | 20 | 4.3 | |
| < 1.5 | 482 | 91.4 | 453 | 98.0 | <0.001 |
| ≥ 1.5 | 45 | 8.6 | 9 | 2.0 | |
| < 0.9 | 76 | 14.4 | 21 | 4.6 | <0.001 |
| ≥ 0.9 | 451 | 85.6 | 441 | 95.4 | |
| < 3.4 | 365 | 69.2 | 352 | 76.2 | NS |
| 3.4–4.0 | 111 | 21.1 | 79 | 17.1 | |
| ≥ 4.1 | 52 | 9.7 | 31 | 6.7 | |
| < 4 | 298 | 56.5 | 370 | 80.1 | <0.001 |
| ≥ 4 | 229 | 43.5 | 92 | 19.9 | |
1 Chi-square test (Fisher's exact test where appropriate) for differences between the genders.2 Not significant.
Relationship between obesity indices and CVD risk factor variables in University of Crete medical students
| < 20.0 | 113 | 112 ± 1.2 | 75 ± 1.0 | 4.50 ± 0.06 | 4.56 ± 0.09 | 0.70 ± 0.04 | 1.36 ± 0.04 | 2.83 ± 0.09 | 3.56 ± 0.13 |
| 20.0–24.9 | 560 | 117 ± 0.5 | 76 ± 0.4 | 4.63 ± 0.03 | 4.57 ± 0.04 | 0.71 ± 0.02 | 1.30 ± 0.02 | 2.87 ± 0.04 | 3.66 ± 0.05 |
| 25.0–29.9 | 273 | 121 ± 0.8 | 79 ± 0.6 | 4.67 ± 0.04 | 4.74 ± 0.06 | 0.80 ± 0.02 | 1.24 ± 0.02 | 3.08 ± 0.06 | 4.07 ± 0.08 |
| ≥ 30.0 | 43 | 123 ± 1.9 | 82 ± 1.5 | 4.77 ± 0.10 | 4.89 ± 0.15 | 1.06 ± 0.06 | 1.25 ± 0.06 | 3.05 ± 0.15 | 4.17 ± 0.21 |
| <0.001 | <0.001 | NS4 | <0.001 | <0.001 | 0.010 | 0.018 | <0.001 | ||
| < 905 – 806 | 716 | 116 ± 0.6 | 76 ± 0.4 | 4.58 ± 0.03 | 4.56 ± 0.04 | 0.69 ± 0.02 | 1.36 ± 0.02 | 2.84 ± 0.04 | 3.54 ± 0.05 |
| ≥ 90 – 80 | 273 | 120 ± 0.9 | 79 ± 0.6 | 4.64 ± 0.04 | 4.74 ± 0.06 | 0.89 ± 0.03 | 1.19 ± 0.02 | 3.05 ± 0.06 | 4.13 ± 0.08 |
| <0.001 | <0.001 | NS | 0.011 | <0.001 | <0.001 | 0.002 | <0.001 | ||
| < 0.95 – 0.86 | 690 | 117 ± 0.6 | 77 ± 0.4 | 4.59 ± 0.03 | 4.58 ± 0.04 | 0.69 ± 0.02 | 1.34 ± 0.02 | 2.88 ± 0.04 | 3.61 ± 0.06 |
| ≥ 0.9 – 0.8 | 299 | 119 ± 0.9 | 78 ± 0.7 | 4.68 ± 0.04 | 4.76 ± 0.07 | 0.88 ± 0.03 | 1.21 ± 0.03 | 3.09 ± 0.06 | 4.21 ± 0.09 |
| NS | NS | NS | 0.019 | <0.001 | <0.001 | 0.003 | <0.001 | ||
| < 50.0 | 732 | 117 ± 0.5 | 76 ± 0.4 | 4.59 ± 0.03 | 4.54 ± 0.04 | 0.69 ± 0.02 | 1.34 ± 0.01 | 2.83 ± 0.04 | 3.57 ± 0.05 |
| ≥ 50.0 | 257 | 129 ± 0.9 | 79 ± 0.7 | 4.64 ± 0.04 | 4.81 ± 0.07 | 0.88 ± 0.03 | 1.25 ± 0.02 | 3.09 ± 0.06 | 4.12 ± 0.08 |
| 0.022 | 0.001 | NS | <0.001 | <0.001 | <0.001 | 0.001 | <0.001 | ||
1 For BG the sample sizes are: N = 79, N = 408, N = 210, and N = 30 respectively for the BMI categories; N = 527 and N = 200 for the WC categories; N = 508 and N = 219 for the WHpR categories; N = 532 and N = 195 for the WHtR categories. 2 Standard error of the mean. 3 F-statistic from ANCOVA including age, sex, tobacco use, and the year of examination as covariates. 4 Not significant. 5 Male-specific cut-off value. 6 Female-specific cut-off value. 7 F-statistic from ANCOVA including age, tobacco use, and the year of examination as coviariates.
Regression analysis of blood pressure, glucose, and lipoproteins on obesity indices in male students1
| BMI | 0.266 | 0.048 | 3.3 | 0.001 | |
| WC | 0.485 | 0.025 | 3.6 | <0.001 | |
| BMI | 0.215 | 0.049 | 4.5 | <0.001 | |
| __ | __ | __ | __ | __ | |
| WHtR | 0.217 | 0.062 | 4.3 | <0.001 | |
| WHtR | 0.263 | 0.106 | 5.5 | <0.001 | |
| WHtR | 0.180 | 0.042 | 3.4 | 0.001 | |
| WHpR | -0.255 | 0.045 | -5.1 | <0.001 | |
| WHtR | 0.244 | 0.073 | 4.7 | <0.001 |
1 N = 527 except for BG analysis where N = 412. 2 All four obesity indices, age, tobacco use and the year of examination were initially included in all regression models.
Regression analysis of blood pressure, glucose, and lipoproteins on obesity indices in female students1
| BMI | 0.346 | 0.119 | 6.6 | <0.001 | |
| BMI | 0.288 | 0.084 | 5.3 | <0.001 | |
| __ | __ | __ | __ | __ | |
| __ | __ | __ | __ | __ | |
| WC | 0.285 | 0.079 | 5.5 | <0.001 | |
| WHtR | 0.161 | 0.023 | 3.0 | 0.003 | |
| WC | -0.270 | 0.076 | -5.2 | <0.001 | |
| TC:HDL-C | WC | 0.312 | 0.100 | 6.1 | <0.001 |
1 N = 462 except for BG analysis where N = 346. 2 All four obesity indices, age, tobacco use and the year of examination were initially included in all regression models.
Risk for the presence of hypertension and dyslipidaemia according to the obesity status
| SBP ≥ 130 mmHg | 1.81 (0.64–5.10) | 1.24 (0.69–2.23) | 1.62 (0.87–3.02) | 1.37 (0.77–2.43) |
| DBP ≥ 85 mmHg | 2.73 (1.13–6.59)2 | 1.38 (0.84–2.27) | 1.11 (0.66–1.87) | 1.46 (0.90–2.37) |
| TC ≥ 5.2 mmol/l | 2.01 (0.80–5.05) | 1.91 (1.18–3.10)3 | 1.70 (1.01–2.84)2 | 2.26 (1.40–3.67)4 |
| TG ≥ 1.5 mmol/l | 2.62 (0.80–8.64) | 1.80 (0.83–3.92) | 2.51 (1.11–5.69)2 | 1.72 (0.78–3.80) |
| LDL-C ≥ 3.4 mmol/l | 1.46 (0.55–6.04) | 1.67 (1.04–2.70)2 | 1.80 (1.09–2.98)2 | 1.83 (1.14–2.94)2 |
| HDL-C < 0.9 mmol/l | 2.39 (0.94–6.04) | 1.61 (1.00–2.58)2 | 2.03 (1.23–3.35)3 | 1.34 (0.84–2.14) |
| TC:HDL-C ≥ 4 | 2.36 (0.86–6.47) | 2.16 (1.38–3.39)4 | 2.78 (1.69–4.57)4 | 2.09 (1.35–3.26)3 |
| SBP ≥ 130 mmHg | 2.98 (0.34–26.12) | 0.87 (0.17–4.33) | 1.16 (0.27–4.98) | 0.71 (0.09–6.00) |
| DBP ≥ 85 mmHg | 3.15 (0.89–11.13) | 1.77 (0.92–3.41) | 1.26 (0.65–2.41) | 2.33 (1.09–4.96)2 |
| TC ≥ 5.2 mmol/l | 1.34 (0.35–5.16) | 1.49 (0.83–2.68) | 0.98 (0.56–1.72) | 1.53 (0.75–3.12) |
| TG ≥ 1.5 mmol/l | 0.01 (0.00–1.53) | 3.80 (0.51–28.13) | 3.44 (0.57–20.67) | 7.19 (0.95–54.49) |
| LDL-C ≥ 3.4 mmol/l | 2.35 (0.66–8.42) | 1.97 (1.12–3.47)2 | 1.32 (0.77–2.26) | 2.60 (1.33–5.07)3 |
| HDL-C < 0.9 mmol/l | 2.77 (0.54–14.26) | 1.98 (0.91–4.29) | 3.33 (1.63–6.79)4 | 2.83 (1.19–6.73)2 |
| TC:HDL-C ≥ 4 | 3.67 (0.99–13.67) | 4.21 (2.35–7.55)4 | 3.71 (2.14–6.41)4 | 5.30 (2.66–10.58)4 |
1 Logistic regression models including age, tobacco use, and the year of examination as independent variables. 2 p < 0.05, 3 p < 0.01, 4 p < 0.001